Sun Pharma plans to invest an additional Rs 200 crore at its plant in the state of Assam to augment operations. Assam Chief Minister Sarbananda Sonowal inaugurated a new production line…Read More
Lupin Limited has appointed Alok Sonig as CEO – US generics and global head – generics R&D and biosimilars. Alok will lead and have overall responsibility for the US generics…Read More
Zydus Cadila has received the final approval from the USFDA to market Exemestane tablets (US RLD – AROMASIN tablets), 25 mg. They will be manufactured at the group’s formulations manufacturing…Read More
Elbrit Life Sciences is now expanding its footprint in the domestic pharmaceutical industry. The company is presently in advanced talks with its parent investment firm, Capital Investments and a Qatar-based…Read More
Ipca Labs’ subsidiary Ipca Pharmaceuticals has acquired 80 percent share capital of New Jersey-headquartered generic drug major, Bayshore Pharmaceuticals Llc for USD 10.286 million. Bayshore had reported a total income…Read More
Piramal Pharma Solutions has launched its Xcelerate Integrated Solutions platform to address a rapidly growing market need. This platform will serve the increasing demand from pharmaceutical firms, both large and…Read More
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration to manufacture and market Azithromycin oral suspension 100 mg/5 mL and 200 mg/5 mL. Azithromycin oral…Read More
The management at pharmaceutical major, Dr Reddy’s Laboratories, has set about trying to bring its house in order, with the considerable time and energy it spent in negotiating an early…Read More
Pharmaceutical major Kusum Group of Companies has launched its latest `90 crore Indore plant at the special economic zone in Pithampur, Madhya Pradesh. Built on an area of over 4.88…Read More
Glenmark Pharmaceuticals has entered into a collaboration with leading, home-grown private equity firm True North for its orthopedic and pain management business for the markets of India and Nepal. Under…Read More
Drug firm GlaxoSmithKline Pharmaceuticals has decided to concentrate on 20 key brands to drive growth going forward. In keeping with their global approach on focusing energy where it matters, GSK…Read More
Jubilant Life Sciences has earmarked Rs 550 crore for capital expenditure (CapEx) in the current financial year. It is also planning to invest Rs 300 crore in research and development (R&D) in…Read More
Zydus Cadila has received the final approval from the US FDA to market Gemfibrozil tablets USP 600 mg (US RLD – Lopid), and Aripiprazole orally disintegrating tablets USP in strengths…Read More
Pharmaceutical giant, Lupin Limited expects to train more than 1000 undergraduates to become pharma professionals by the year 2020 under its Learn and Earn initiative. Lupin has launched this initiative…Read More
Novartis has agreed to sell selected portions of its Sandoz US portfolio, specifically the Sandoz US dermatology business and generic US oral solids portfolio, to Aurobindo Pharma, for USD 0.9…Read More
Recent Comments